4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-105330
Chief Development Officer sold 14 shares at $71.77 ($1,005)
- Chief Development Officer acquired 14 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2025-08-05 | Option exercise 10b5-1 | +14 | $21.65 | $303 | 5,501 | D |
| Guyer William Chief Development Officer | 2025-08-05 | Sale 10b5-1 | −14 | $71.77 | $1,005 | 5,487 | D |
| Derivatives | |||||||
| Guyer William Chief Development Officer | 2025-08-05 | Option exercise · Stock option (right to buy) 10b5-1 | −14 | 385,007 | D | ||
| Open-market sales · 14 sh · avg $71.77 · $1,005 | |||||||
Loading xslF345X05/ownership.xml…